Kobayashi, S., Takahashi, C., Kuroda, T., Sugenoya, A., Iida, F
Most patients using GHK-Cu at our Doral clinic are also on NAD+ because the two serve the same demographic: people investing in long-term health optimization
Huang Y, Wu X, Guo J, Yuan J
Follow-up Repeat broad and inflammation markers after 6-12 weeks if symptoms change or the protocol continues
However, exogenous SOD supplements face significant challenges in providing similar benefits unless specially formulated to enhance delivery
However, the convenience and accessibility of oral capsules cannot be understated, making them a preferred choice for regular maintenance and long-term health goals